TearScience
TearScience is an American company founded in 2005 that develops, manufactures and markets ophthalmic medical devices aiding in the identification and treatment of meibomian gland dysfunction, which can lead to dry eye disease, which is a…
≈ 3 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
TearScience is an American company founded in 2005 that develops, manufactures and markets ophthalmic medical devices aiding in the identification and treatment of meibomian gland dysfunction, which can lead to dry eye disease,[1] which is a condition that affect as many as 25 million Americans. The company's Lipiflow System was FDA cleared in June 2011 for treating meibomian gland dysfunction[2] and is currently installed in over 250 locations across the globe. The company is headquartered in Morrisville, North Carolina.
Products
edit edit sourceLipiView Ocular Surface uses interferometry to measure the thickness of the tear film oily lipid layer.[3] LipiFlow Thermal Pulsation System uses heat and pressure to unblock obstructed meibomian glands[4] to reduce dry eye symptoms.[5]
References
edit edit source- ^ "Hawaiian Eye & Retina 2021 Meeting - Home". www.healio.com. Retrieved 2020-07-27. Wikipedia revision 1304956303, retrieved 2026-11-18
- ^ Lane SS, et al. (2012). "A new system, the LipiFlow, for the treatment of meibomian gland dysfunction". Cornea. 31 (4): 396–404. doi:10.1097/ico.0b013e318239aaea. PMID 22222996. Wikipedia revision 1304956303, retrieved 2026-11-18
- ^ Eom Y, Lee JS, Kang SY, Kim HM, Song JS (June 2013). "Correlation between quantitative measurements of tear film lipid layer thickness andmeibomian gland loss in patients with obstructive meibomian gland dysfunction and normal controls". American Journal of Ophthalmology. 155 (6). Epub 2013 Mar 7: 1104–1110. doi:10.1016/j.ajo.2013.01.008. PMID 23465270. Wikipedia revision 1304956303, retrieved 2026-11-18
- ^ Korb DR, Blackie CA (August 2010). "Restoration of meibomian gland functionality with novel thermodynamic treatment device-a case report". Cornea. 29 (8): 930–933. doi:10.1097/ICO.0b013e3181ca36d6. PMID 20531168. Wikipedia revision 1304956303, retrieved 2026-11-18
- ^ Greiner JV. (April 2012). "A single LipiFlow® Thermal Pulsation System treatment improves meibomian glandfunction and reduces dry eye symptoms for 9 months". Current Eye Research. 37 (4): 272–278. doi:10.3109/02713683.2011.631721. PMID 22324772. Wikipedia revision 1304956303, retrieved 2026-11-18
External links
edit edit source- Official website
- Wall Street Journal "More Dry Eyes in the House"
- Review of Optometry "Dry Eye Measurement Lipiview Ocular Surface Interferometer"[permanent dead link]
- MedCity News "Medical device dry-eye treatment LipiFlow wins FDA approval
Text derived from https://en.wikipedia.org/w/index.php?oldid=1304956303 under CC BY-SA 4.0; modifications have been made.
References
- ↩Wikipedia “TearScience” date of foundation (×1) · confidence 0.95 revision URL